Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma.
Vajavaara H, Ekeblad F, Holte H, Jorgensen J, Leivonen SK, Berglund M, Kamper P, Moller HJ, D'Amore F, Molin D, Enblad G, Ludvigsen M, Glimelius I, Leppa S. Vajavaara H, et al. Among authors: molin d, d amore f. Haematologica. 2021 Sep 1;106(9):2502-2506. doi: 10.3324/haematol.2020.278182. Haematologica. 2021. PMID: 33764002 Free PMC article. No abstract available.
High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome.
Hollander P, Kamper P, Smedby KE, Enblad G, Ludvigsen M, Mortensen J, Amini RM, Hamilton-Dutoit S, d'Amore F, Molin D, Glimelius I. Hollander P, et al. Among authors: molin d, d amore f. Blood Adv. 2017 Aug 8;1(18):1427-1439. doi: 10.1182/bloodadvances.2017006346. eCollection 2017 Aug 8. Blood Adv. 2017. PMID: 29296784 Free PMC article.
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.
Lagerlöf I, Holte H, Glimelius I, Björkholm M, Enblad G, Erlanson M, Fluge Ø, Fohlin H, Fosså A, Goldkuhl C, Gustavsson A, Johansson AS, Linderoth J, Nome O, Palma M, Åkesson L, Østenstad B, Raud C, Glimelius B, Molin D. Lagerlöf I, et al. Among authors: molin d. Br J Haematol. 2020 Mar;188(5):685-691. doi: 10.1111/bjh.16232. Epub 2019 Oct 14. Br J Haematol. 2020. PMID: 31612478 Free article. Clinical Trial.
Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy.
Lagerlöf I, Fohlin H, Enblad G, Glimelius B, Goldkuhl C, Palma M, Åkesson L, Glimelius I, Molin D. Lagerlöf I, et al. Among authors: molin d. J Clin Oncol. 2022 May 1;40(13):1487-1496. doi: 10.1200/JCO.21.02407. Epub 2022 Jan 25. J Clin Oncol. 2022. PMID: 35077204 Free PMC article.
151 results